Mizuho Securities analyst Vikram Malhotra has reiterated their bullish stance on WELL stock, giving a Buy rating yesterday.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Vikram Malhotra has given his Buy rating due to a combination of factors demonstrating Welltower’s strong financial performance and potential for future growth. The company’s fourth-quarter financial results slightly surpassed expectations, and its guidance for the fiscal year 2025 is about 3% above market predictions. This positive outlook is supported by Welltower’s solid cash flow growth projection, pricing power in senior housing, and an expanding non-same-store pool, which is expected to enhance cash flow further.
Additionally, Welltower’s effective management of expenses and debt levels contributes to its strong financial position. The company’s net debt to EBITDA ratio has improved, and its AFFO per share growth remains robust. The firm’s strategic acquisitions and external growth initiatives have also bolstered its market standing, making it a top pick for investors seeking solid returns in the healthcare real estate sector.
In another report released yesterday, Morgan Stanley also maintained a Buy rating on the stock with a $145.00 price target.
Based on the recent corporate insider activity of 27 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of WELL in relation to earlier this year.